Where ODA intervention outcomes cannot be monetised, can they be quantified?
Background
IRIA aims to build an evidence base useful for monitoring the effectiveness of UK international research collaboration, determining the value-for-money of international R&I interventions and comparing the UK with other countries. We support a wide range of programmes as well as building an evidence base that can be used for new interventions. This includes government plans to protect and support UK science, research, technology and innovation (SRTI) sectors, should association to Horizon Europe on fair and appropriate terms not be possible.
We are interested in assessing the value delivered from infrastructure which supports research and innovation, such as laboratories or institution headquarters. An example of this is the project to relocate the European Centre for Medium-Range Weather Forecasts (ECMWF) to the University of Readings’ campus.
We seek to provide monetised estimates of the impact of international R&I, especially international collaboration in R&I. This is salient for collaboration between more economically developed countries (or HMG non-ODA interventions) but is also relevant for collaboration between the UK and less economically developed countries (or HMG ODA interventions). We are also interested in being able to quantify ODA outcomes which cannot be appropriately monetised. The aim is to build an evidence base comparable to domestic impacts of R&I, for example by addressing questions including:
Next steps
If you are keen to register your interest in working and connecting with DSIT Science, Innovation, and Research Directorate, and/or submitting evidence, then please complete the DSIT-ARI Evidence survey - https://dsit.qualtrics.com/jfe/form/SV_cDfmK2OukVAnirs
Link to ARIs : https://www.gov.uk/government/publications/department-for-science-innovation-and-technology-areas-of-research-interest/dsit-areas-of-research-interest-2024
Topics
Related UKRI funded projects
-
Investigation of the impact of co-location: economies of scope and scale in biomedical and health research
It is important to achieve the best outcomes from public sector investments in medical research. To do this, research funders need to understand where they should invest the limited funds they have available to maximise ...
Funded by: MRC
Why might this be relevant?
Partially relevant as it investigates the impact of co-location in biomedical research, but does not specifically address ODA intervention outcomes.
-
Novel method for tracking the translation processes that lead to impact from Biomedical research - A pilot study
The MRC Economic Impact call states that "The MRC wishes to understand better the link between research and wider economic and societal impacts, and to use this understanding to improve strategies for the future sup...
Funded by: MRC
Why might this be relevant?
Partially relevant as it focuses on tracking translation processes in biomedical research, but does not specifically address ODA intervention outcomes.
-
Understanding the relative valuations of research impact: Applying best-worst scaling experiments to survey the public & biomedical/health researchers
Research Councils "encourage researchers to consider the potential contribution that their research can make to the economy and society from the outset, and the resources required to carry out appropriate and projec...
Funded by: MRC
Why might this be relevant?
Fully relevant as it aims to survey the public and researchers to understand the relative valuations of research impact, including ODA outcomes that cannot be monetised.